1. Home
  2. VNDA vs AEHR Comparison

VNDA vs AEHR Comparison

Compare VNDA & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • AEHR
  • Stock Information
  • Founded
  • VNDA 2002
  • AEHR 1977
  • Country
  • VNDA United States
  • AEHR United States
  • Employees
  • VNDA N/A
  • AEHR N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • AEHR Electrical Products
  • Sector
  • VNDA Health Care
  • AEHR Industrials
  • Exchange
  • VNDA Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • VNDA 261.7M
  • AEHR 214.5M
  • IPO Year
  • VNDA 2006
  • AEHR 1997
  • Fundamental
  • Price
  • VNDA $4.68
  • AEHR $14.23
  • Analyst Decision
  • VNDA Strong Buy
  • AEHR
  • Analyst Count
  • VNDA 3
  • AEHR 0
  • Target Price
  • VNDA $15.33
  • AEHR N/A
  • AVG Volume (30 Days)
  • VNDA 424.5K
  • AEHR 1.1M
  • Earning Date
  • VNDA 07-30-2025
  • AEHR 07-08-2025
  • Dividend Yield
  • VNDA N/A
  • AEHR N/A
  • EPS Growth
  • VNDA N/A
  • AEHR 50.16
  • EPS
  • VNDA N/A
  • AEHR 0.78
  • Revenue
  • VNDA $201,351,000.00
  • AEHR $61,479,000.00
  • Revenue This Year
  • VNDA $16.86
  • AEHR N/A
  • Revenue Next Year
  • VNDA $39.78
  • AEHR $22.53
  • P/E Ratio
  • VNDA N/A
  • AEHR $18.15
  • Revenue Growth
  • VNDA 13.37
  • AEHR N/A
  • 52 Week Low
  • VNDA $3.81
  • AEHR $6.27
  • 52 Week High
  • VNDA $6.37
  • AEHR $21.44
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 57.93
  • AEHR 62.76
  • Support Level
  • VNDA $4.38
  • AEHR $11.06
  • Resistance Level
  • VNDA $4.95
  • AEHR $13.47
  • Average True Range (ATR)
  • VNDA 0.14
  • AEHR 0.77
  • MACD
  • VNDA 0.01
  • AEHR 0.05
  • Stochastic Oscillator
  • VNDA 54.39
  • AEHR 68.22

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: